John E. Abele, Director at BOSTON SCIENTIFIC CORP (BSX), sold 75,000 shares at $6.04 ($453K) on 2010-07-22, disclosed to the SEC on 2010-07-26.
Scheduled sale ($452k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.03 | 50,000 | $302K | 66.6% |
| 2 | $6.04 | 25,000 | $151K | 33.4% |
| Total | $6.03 avg | 75,000 | $453K | 100% |
| Filing → |
| BSX | BUY | 2015-08-18 | $1.8M | — | Filing → |
| BSX | SELL | 2010-08-19 | $23K | — | Filing → |
| BSX | SELL | 2010-08-18 | $273K | — | Filing → |